The Promonitor family of tests measures both drug levels and anti-drug antibody levels with validated ELISA assays to complement biological therapies for drug monitoring. Testing for drug bioavailability and immunogenicity: IFX, Anti-IFX, ADL, Anti-ADL, RTX, Anti-RTX, ETN, Anti-ETN, GLM, Anti-GLM, VDZ, Anti-VDZ, UTK, Anti-UTK.
Refine treatment of chronic inflammatory diseases with a personalized approach to therapy with biologics.
Reduce the use of ineffective treatment strategies, allowing a more efficient use of available resources.
Quickly generate results with ELISA-based tests and readily available equipment.
Expand lab operations and workflow with multiple tests and configurations.
Rely on results with a high quality product.
Evaluation studies have demonstrated that Promonitor kits are able to quantify not only biological drug levels, but also biosimilar drugs.